These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34706096)

  • 1. Feedback-regulated transcriptional repression of FBXO31 by c-Myc triggers ovarian cancer tumorigenesis.
    Islam S; Dutta P; Sahay O; Gopalakrishnan K; Muhury SR; Parameshwar P; Shetty P; Santra MK
    Int J Cancer; 2022 May; 150(9):1512-1524. PubMed ID: 34706096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCF
    Choppara S; Ganga S; Manne R; Dutta P; Singh S; Santra MK
    J Biol Chem; 2018 Oct; 293(42):16291-16306. PubMed ID: 30171069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
    Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
    Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
    Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress.
    Malonia SK; Dutta P; Santra MK; Green MR
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8632-7. PubMed ID: 26124108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.
    Santra MK; Wajapeyee N; Green MR
    Nature; 2009 Jun; 459(7247):722-5. PubMed ID: 19412162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
    Kumar R; Neilsen PM; Crawford J; McKirdy R; Lee J; Powell JA; Saif Z; Martin JM; Lombaerts M; Cornelisse CJ; Cleton-Jansen AM; Callen DF
    Cancer Res; 2005 Dec; 65(24):11304-13. PubMed ID: 16357137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.
    Dutta P; Islam S; Choppara S; Sengupta P; Kumar A; Kumar A; Wani MR; Chatterjee S; Santra MK
    J Biol Chem; 2019 Oct; 294(41):14879-14895. PubMed ID: 31413110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation.
    Chen K; Wang Y; Dai X; Luo J; Hu S; Zhou Z; Shi J; Pan X; Cao T; Xia J; Li Y; Wang Z; Ma J
    Cell Death Dis; 2024 Jan; 15(1):37. PubMed ID: 38216561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
    Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
    Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a.
    Zhang X; Kong Y; Xu X; Xing H; Zhang Y; Han F; Li W; Yang Q; Zeng J; Jia J; Liu Z
    Oncotarget; 2014 Aug; 5(15):6178-90. PubMed ID: 25115392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCF
    Li Y; Jin K; Bunker E; Zhang X; Luo X; Liu X; Hao B
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):319-324. PubMed ID: 29279382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
    Johansson P; Jeffery J; Al-Ejeh F; Schulz RB; Callen DF; Kumar R; Khanna KK
    J Biol Chem; 2014 Jun; 289(26):18514-25. PubMed ID: 24828503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).
    Liu J; Han L; Li B; Yang J; Huen MS; Pan X; Tsao SW; Cheung AL
    J Biol Chem; 2014 Aug; 289(31):21508-18. PubMed ID: 24936062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A MicroRNA/Ubiquitin Ligase Feedback Loop Regulates Slug-Mediated Invasion in Breast Cancer.
    Manne RK; Agrawal Y; Bargale A; Patel A; Paul D; Gupta NA; Rapole S; Seshadri V; Subramanyam D; Shetty P; Santra MK
    Neoplasia; 2017 Jun; 19(6):483-495. PubMed ID: 28500896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.
    Jeffery JM; Kalimutho M; Johansson P; Cardenas DG; Kumar R; Khanna KK
    Oncogene; 2017 Feb; 36(7):1012-1022. PubMed ID: 27568981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
    Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
    Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.